A drugmaker says it will no longer market its opioid products in doctors' offices after facing backlash for the way the industry promotes the addictive drugs.
OxyContin maker Purdue Pharma said it will tell doctors about its decision Monday. As part of the plan, the company has cut its sales force in half.
Opioids killed more than 42,000 people in 2016 according to the Centers for Disease Control and Prevention, and 40 percent of those deaths involved a prescription opioid.
Doctors who want information on opioids will now need to contact the company's medical affairs department.